SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-127627
Filing Date
2020-04-30
Accepted
2020-04-30 07:19:46
Documents
14
Period of Report
2020-04-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d924138d8k.htm   iXBRL 8-K 27598
2 EX-99.1 d924138dex991.htm EX-99.1 72611
6 GRAPHIC g924138pic2.jpg GRAPHIC 6502
  Complete submission text file 0001193125-20-127627.txt   242662

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA agio-20200430.xsd EX-101.SCH 3048
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20200430_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20200430_pre.xml EX-101.PRE 10938
13 EXTRACTED XBRL INSTANCE DOCUMENT d924138d8k_htm.xml XML 3236
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36014 | Film No.: 20833133
SIC: 2834 Pharmaceutical Preparations